Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06070649
PHASE1
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
Sponsor: Yale University
View on ClinicalTrials.gov
Summary
This proposed study is a double-blind, randomized, placebo-controlled, parallel-group, laboratory study to determine the effects of DMT, plus psychotherapy, on Alcohol Use Disorder.
Key Details
Gender
All
Age Range
21 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
63
Start Date
2025-08-04
Completion Date
2026-08-01
Last Updated
2025-12-23
Healthy Volunteers
No
Interventions
DRUG
0.3mg/kg/min Dimethyltryptamine + Normal Saline infusion
Infusion
DRUG
0.2 mg/kg/min + Dimethyltryptamine 0.01mg/kg/min infusion
Infusion
DRUG
25 mg Diphenhydramine (5 min) + Normal Saline
Infusion
Locations (1)
Connecticut Mental Health Center
New Haven, Connecticut, United States